Skip to main content
. Author manuscript; available in PMC: 2014 May 2.
Published in final edited form as: Clin Cancer Res. 2012 Sep 17;18(21):6058–6064. doi: 10.1158/1078-0432.CCR-11-3251

Table 4.

Neurologic toxicity regardless of attribution while on MLN8237

Part and schedule Dose level (mg/m2/dose) Pt. no. Description and grade
A1 (daily) 45 4 Somnolence, Gr 2
5 Anxiety, Gr 1; depression, Gr 1; somnolence, Gr 2
6 Depression, Gr 2
7 Agitation, Gr 1
60 13 Somnolence, Gr 2; memory impairment, Gr 2
80 15 Euphoria, Gr 2
16 Depression, Gr 4a
17 Agitation; Gr 2
19 Depression, Gr 1
100 20 Agitation, Gr 1
21 Somnolence, Gr 2; dizziness, Gr 1
23 Agitation, Gr 1
24 Dizziness, Gr 1
A2 (twice daily) 40 27 Personality/behavioral, Gr 1
29 Somnolence, Gr 2
31 Depression, Gr 1; dysphoria, Gr 1
30 32 Agitation, Gr 1
36 Personality/behavioral, Gr 1
a

Grade 1 depression at baseline.